Spyre Therapeutics, Inc. · NASDAQ:SYRE

Harwin Peter Evan reported a 9.99% stake in Spyre Therapeutics, Inc. (Schedule 13D/A)

Event Oct 7, 2026 · Filed Oct 9, 2026

Harwin Peter Evan reported a 9.99% stake in Spyre Therapeutics, Inc., 10,185,961 shares, with active intent on Oct 7, 2026. Filed Oct 9, 2026 (Schedule 13D/A).

Stake
9.99%
Shares
10,185,961
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC9.19%9,354,200
Fairmount Healthcare Fund II L.P.9.19%9,354,200
Harwin Peter Evan9.99%10,185,961
Kiselak Tomas9.99%10,185,961

Source

View original at SEC

Related